Mendelian Randomization Study Evidence On The Association Between Herpes Simplex Virus Antibodies Immune Response And The Risk Of Drug-Induced Obesity
Clinical Medicine and Pharmacology · 2025
DOI: 10.70731/thgpbr97 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine and Pharmacology, 2025. Verfasst von Xiaoping Li und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study utilized Mendelian randomization (MR) to investigate the causal link between immune response to herpes simplex virus antibodies and drug-induced obesity (DIO). Genome-wide association study (GWAS) data was analyzed using methods like Inverse Variance Weighted (IVW), MR-Egger, and Weighted Median method (WME). Effective instrumental variables were identified, showing a significant increase in DIO risk with Epstein-Barr virus ZEBRA antibody, herpes simplex virus 7 U14 antibody, herpes simplex virus type 1 IgG, and herpes simplex virus type 2 IgG seropositivity. Reverse MR analysis did not reveal a reverse causal relationship. The study provides initial evidence of the relationship between herpes simplex virus antibody immune response and DIO, contributing new theoretical insights for future understanding of DIO.
Zitieren
APA
Li, X., Zhao, W., Li, Y., & Chen, H. (2025). Mendelian Randomization Study Evidence On The Association Between Herpes Simplex Virus Antibodies Immune Response And The Risk Of Drug-Induced Obesity. Clinical Medicine and Pharmacology. https://doi.org/10.70731/thgpbr97
Vancouver
Li X, Zhao W, Li Y, Chen H. Mendelian Randomization Study Evidence On The Association Between Herpes Simplex Virus Antibodies Immune Response And The Risk Of Drug-Induced Obesity. Clinical Medicine and Pharmacology. 2025. doi:10.70731/thgpbr97
BibTeX
@article{Li2025,
author = {Li, Xiaoping and Zhao, Weikun and Li, Yanni and Chen, Hong},
title = {Mendelian Randomization Study Evidence On The Association Between Herpes Simplex Virus Antibodies Immune Response And The Risk Of Drug-Induced Obesity},
journal = {Clinical Medicine and Pharmacology},
year = {2025},
doi = {10.70731/thgpbr97}
}
EUVIMED